Delivery Order SPE2DE24D0013-SPE2D626F702E
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $14,960 firm fixed-price delivery order to Cepheid Inc. on November 20, 2025, with an ultimate completion date of December 5, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, represents a relatively modest procurement within Cepheid's broader federal contracting portfolio and likely involves molecular diagnostic reagents or test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's...
- Cepheid Inc. was awarded a $4,838.52 firm fixed-price delivery order (4569983524) by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with completion expected by November 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves molecular diagnostic testing reagents and assays for the GeneXpert diagnostic platform, specifically cartridges designed to detect COVID-19, influenza, and respiratory syncytial virus. The work will be performed at Cepheid's facility...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $23,120 to Cepheid Inc. on November 13, 2025, with an ultimate completion date of November 20, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The work will be performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $4,080 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for the detection of COVID-19, influenza, and respiratory syncytial virus. This award carries no set-aside designation and represents a...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, was awarded a delivery order valued at $8,976 on December 3, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as XPCOV2/FLU/RSV-10, is a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and carries no set-aside designation. The contract supports the procurement of diagnostic testing supplies, specifically reagents and...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,440 on December 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by December 12, 2025, and will be performed at the contractor's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F702EDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $119,935.20 firm fixed-price delivery order to Cepheid Inc. on December 3, 2025, with an ultimate completion date of December 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic reagents and test cartridges for respiratory pathogen detection, specifically products designed for Cepheid's GeneXpert molecular diagnostic platform. The work will be performed at Cepheid's headquarters in Sunnyvale, California. This is a non-set-aside procurement, reflecting Cepheid's established competitive position as a primary federal supplier of molecular diagnostic solutions across the Defense and Veterans Affairs healthcare systems. Cepheid has demonstrated substantial capability as a federal contractor through extensive prior awards from multiple healthcare agencies, including the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and U.S. Coast Guard. The company currently maintains two significant Indefinite Delivery Contracts with the VA—one with VISN 17 valued at $6.7 million through December 2029 and another with VISN 6 valued at $32.8 million through September 2030—both supporting procurement of molecular diagnostic reagents and testing systems. The current delivery order represents routine fulfillment of Cepheid's role in supplying critical diagnostic capabilities for federal detection of COVID-19, influenza, and respiratory syncytial virus across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119.9k | 12/2/25 |